Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3pgF88r
Posts
Pfizer Stuns Experts With Early Data that Vaccine Is More Than 90% Effective
By BY KATIE THOMAS, DAVID GELLES AND CARL ZIMMER from NYT Health https://ift.tt/3n7zROU
Shot to Prevent H.I.V. Works Better Than Daily Pill in Women
By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3n6giq5
An Explanation for Some Covid-19 Deaths May Not Be Holding Up
By BY GINA KOLATA from NYT Health https://ift.tt/3573ycs
Controversial Alzheimer’s Drug Faces Critical Test Before F.D.A. Panel
By BY PAM BELLUCK from NYT Health https://ift.tt/3jZ7hgp
$26 Billion Settlement Offer in Opioid Lawsuits Gains Wide Support
By BY JAN HOFFMAN from NYT Health https://ift.tt/2TWytC3
A Rapid Virus Test Falters in People Without Symptoms, Study Finds
By BY KATHERINE J. WU from NYT Health https://ift.tt/3mKjAir
Crispr Gene Editing Can Cause Unwanted Changes in Human Embryos, Study Finds
By BY KATHERINE J. WU from NYT Health https://ift.tt/3kLFxgq
Will the Hardest-Hit Communities Get the Coronavirus Vaccine?
By BY GINA KOLATA from NYT Health https://ift.tt/35OQXKk
Death Rates Have Dropped for Seriously Ill Covid Patients
By BY RONI CARYN RABIN from NYT Health https://ift.tt/34DCT7a
This Addiction Treatment Works. Why Is It So Underused?
By BY ABBY GOODNOUGH from NYT Health https://ift.tt/34BjHa9
UnitedHealth Ships Flu Kits to Medicare Recipients
By BY EMMA GOLDBERG from NYT Health https://ift.tt/34rctVK
Experts Tell F.D.A. It Should Gather More Safety Data on Covid-19 Vaccines
By BY KATIE THOMAS from NYT Health https://ift.tt/3okK5wL
The Pandemic’s Real Toll? 300,000 Deaths, and It’s Not Just From the Coronavirus
By BY RONI CARYN RABIN from NYT Health https://ift.tt/3lZKQJs
Doctors May Have Found Secretive New Organs in the Center of Your Head
By BY KATHERINE J. WU from NYT Health https://ift.tt/2Hn0KPi
Some Signs of Recovery From Severe Covid Lung Damage
By BY LINA ZELDOVICH from NYT Health https://ift.tt/349JK7U
Pfizer Says It Won’t Seek Vaccine Authorization Before Mid-November
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3j6bz5j